1. Q23 A double blind, cross over, placebo-controlled, phase II trial of Sativex in Huntington's Disease. (29th August 2012) Authors: Caldentey, JG; Lopéz-Sendón, JL; Trigo, P; Ruiz, C; Ribas, GG; Aguilar, M; Galvez, MA; Pablo, I; Galve-Roth, I; Sagredo, O; Fernandez-Ruiz, JJ; Guzman, M; García, J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗